Specialty Pharmacy

Newly discovered epigenetic markers offer hope.

Study reveals targets on the tumor cell that can be recognized by killer T-cells.

Top recent developments in cancer research.

Planned Parenthood funding cuts would save taxpayers $235 million over a decade, but also reduce health care access for nearly 400,000 women and children.

Physical and mental impairments prevent MS patients from being engaged in social and community activities.

Clinical signs and symptoms of RA may be preceded by a preclinical phase lasting several years.

GOLD group classification system could not predict lung function decline.

Top stories in Specialty Pharmacy Times.

Lymphoma and lung cancer present significant risk to RA patients.

Birth control use not found to impact disease progression.

Patients who received immediate treatment recommendations saw improved symptom control.

Research will lead to novel viral and immunologic treatments.

Research may lead to antibody treatment to inhibit HIV.

Implications of the IPF treatment for caregivers and patients.

Study finds most patients with Lynch syndrome are unaware they have the syndrome.

Combination of immunotherapy and aspirin showed a substantial decrease in bowel and melanoma skin cancer growth in mice.

Genetic variants regulate immune cells with important roles in immunodeficiency disorders.

Inflammation and joint damage might not be the only factor causing pain in rheumatoid arthritis.

Treatment removes a tumor's defenses.

Chemotherapy drugs can convert gastrointestinal bacteria into toxic species that causes severe diarrhea.

Tourists with prescriptions for medical marijuana will be able to apply for a permit to let them buy it in Jamaica.

Acupuncture found to help patients manage debilitating side effects from breast cancer treatment.

Researchers seek to improve care for rare, difficult-to-treat, and aggressive cancers.

Caregivers need to help patients with psoriasis understand the importance of lifestyle behavior choices.

Adoptive cell transfer procedure involves extracting and growing immune cells outside of the body.

A federal district court has dismissed a lawsuit brought by pharmacy benefits managers (PBMs) against drug pricing transparency legislation in Iowa.

Anticancer medication response strongly linked to genetic ancestry.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses how specialty pharmacies can best navigate complex reporting requirements from multiple entities.